THIS CASE BEGAN WITH AN EPA INSPECTION OF ALBEMARLE'S FACILITY IN ORANGEBURG, SC, IN JULY 2005. THE STATE OF SC PARTICPATED IN PORTIONS OF THE INSPECTION. DURING THE INSPECTION SEVERAL CAA VIOLATIONS WERE IDENTIFIED. EPA IDENTIFIED SEVERAL VIOLATIONS OF THE NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS FOR PHARMACEUTICAL PRODUCTS, 40 CFR 63 SUBPART GGG. EPA ALSO IDENTIFIED A LESSER NUMER OF VIOLATIONS OF THE NATIONAL EMISSIONS STANDARDS FOR MISCELLANEOUS ORGANIC CHEMICAL MANUFACTURG, 40 CFR PART 63, SUBPART FFFF (MON), AND THE NEW SOURCE PERFORMANCE STANDARDS (NSPS) OF SECTION 111 OF THE CAA, AS IMPLEMENTED BY REGS AT 40 CFR PART 60, SUBPARTS A (GENERAL PROVISIONS) AND VV (STANDARDS OF PERFORMANCE FOR THE EQUIPMENT LEAKS OF VOC IN THE SYNTHETIC ORGANIC CHEMICALS MANUFACTURING INDUSTRY).